{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004708","form_type":"8-K","ticker":"ABUS","cik":"0001447028","company_name":"Arbutus Biopharma Corp","filed_at":"2026-07-16T11:31:17+00:00","discovered_at":"2026-07-16T11:35:00.195231+00:00","generated_at":"2026-07-16T11:35:11.867971+00:00","sec_items":["1.02","5.02","8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Arbutus receives $178M from Moderna settlement, files patent suits against Pfizer/BioNTech, plans $230M share repurchase","bullets":["Received approximately $178M from Moderna as its share of noncontingent settlement payment on July 8, 2026.","Filed three international patent infringement lawsuits against Pfizer/BioNTech in Canada and UPC seeking injunctions and damages.","Entered termination agreement with Genevant for RSV agreement, with Genevant paying $1.0M termination fee.","Approved one-time cash bonuses for CEO Lindsay Androski (1.5% of $178M) and CFO Tuan Nguyen (0.25% of proceeds).","Plans to return up to $230M to shareholders via share repurchases in Q3 2026 after receiving dividend from Genevant parent."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004708","json":"https://secwatch.observer/filing/0001171843-26-004708.json","markdown":"https://secwatch.observer/filing/0001171843-26-004708.md","text":"https://secwatch.observer/filing/0001171843-26-004708.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326004708/0001171843-26-004708-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326004708/f8k_071626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T11:35:11.867971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}